Injectable formulations

TW202629152APending Publication Date: 2026-07-16PELTHOS THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
PELTHOS THERAPEUTICS INC
Filing Date
2025-10-23
Publication Date
2026-07-16

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

This invention relates to a pharmaceutical formulation comprising 2-{[3-(5-chloro-2-{2-chloro-5-fluoro-4-[(1,3-thiazolyl-4-yl)aminesulfonyl]phenoxy}phenyl)propyl]amino}acetamide or a pharmaceutically acceptable salt thereof for prolonged release, a method for its preparation, and its use for treating pain or providing perioperative anesthesia or postoperative analgesia. The present invention relates to pharmaceutical formulations comprising 2-{[3-(5-chloro-2-{2-chloro-5-fluoro-4-[(1,3-thiazol-4-yl)sulfamoyl]phenoxy}phenyl)propyl]amino}acetamide, or a pharmaceutically acceptable salt thereof, for extended release, to methods for preparation thereof, and to uses thereof for treatment of pain or providing peri-operative anesthesia or post-operative analgesia.
Need to check novelty before this filing date? Find Prior Art